Table 2.
Parameter | Bromfenac 0.07%, n (%) | Placebo, n (%) |
---|---|---|
Overall study completion | 213/222 (95.9%) | 202/218 (92.7%) |
Full treatment (16 doses) received | 143/222 (64.4%) | 100/218 (45.8%)a |
Percent compliance | 91.2% | 75.9%b |
Notes: This was statistically significant (P=0.0001);
this was statistically significant (P<0.0001).